AVBP

Arrivent Biopharma Inc

• TipRanks·05/19 23:10

  Analysts Are Bullish on These Healthcare Stocks: Climb Bio (CLYM), ArriVent BioPharma, Inc. (AVBP)

• TipRanks·05/17 16:46

  LifeSci Capital Remains a Buy on ArriVent BioPharma, Inc. (AVBP)

• Seeking Alpha·05/16 13:32

  ArriVent BioPharma: Stronger Balance Sheet And Pipeline Upside Reinforce Our Bull Case

• Dow Jones·05/13 18:56

  ArriVent BioPharma Is Maintained at Buy by Citigroup

• Dow Jones·05/13 18:56

  ArriVent BioPharma Price Target Cut to $43.00/Share From $45.00 by Citigroup

• Benzinga·05/13 18:46

  Citigroup Maintains Buy on ArriVent BioPharma, Lowers Price Target to $43

• TipRanks·05/13 10:44

  ArriVent Biopharma price target lowered to $43 from $45 at Citi

• TipRanks·05/12 12:01

  ArriVent BioPharma, Inc. (AVBP) Receives a Buy from Oppenheimer

• TipRanks·05/12 11:51

  Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)

• TipRanks·05/12 10:40

  H.C. Wainwright Reaffirms Their Buy Rating on ArriVent BioPharma, Inc. (AVBP)

• TipRanks·05/12 10:15

  ArriVent Reaffirmed at Buy as Lead Asset Nears 2026 Phase 3 Readout; $42 Price Target Maintained

• TipRanks·05/11 21:53

  ArriVent BioPharma Updates At-The-Market Equity Offering Program

• TipRanks·05/11 21:38

  ArriVent Biopharma reports Q1 EPS (96c), consensus (89c)

• Seeking Alpha·05/11 20:57

  ArriVent BioPharma GAAP EPS of -$0.96 misses by $0.10

• Benzinga·05/11 20:52

  ArriVent Biopharma Launches $250M At-The-Market Common Stock Offering Through Jefferies